Skip to main content
REDS-IV-P Optimizing Transfusion Across the Lifespan - Login Page

Login to REDS-IV-P

Enter your email address.
Enter the password that accompanies your email address.
  • Request new account
  • Reset your password

DAR Submission 1365

Read more about DAR Submission 1365
Webform Submission ID
1365
Status
DAR approved, analysis in progress

DAR Submission 1364

Read more about DAR Submission 1364
Webform Submission ID
1364
Status
DAR approved, analysis in progress

Associations of ABO Non-identical Platelet Transfusion and Patient Outcomes-A Multicenter Retrospective Analysis

Read more about Associations of ABO Non-identical Platelet Transfusion and Patient Outcomes-A Multicenter Retrospective Analysis

How do we build a comprehensive Vein-to-Vein (V2V) database for conduct of observational studies in transfusion medicine? Using the REDS-IV-P V2V data build as an example.

Read more about How do we build a comprehensive Vein-to-Vein (V2V) database for conduct of observational studies in transfusion medicine? Using the REDS-IV-P V2V data build as an example.

RBC-Omics: Negative effect of sphingosine 1-phosphate on red blood cell storage quality mediated by increased activation of glycolysis at the expense of the pentose phosphate pathway

Read more about RBC-Omics: Negative effect of sphingosine 1-phosphate on red blood cell storage quality mediated by increased activation of glycolysis at the expense of the pentose phosphate pathway

Frequent detection but lack of infectivity of SARS-CoV-2 RNA in pre-symptomatic, infected blood donor plasma (Aim 3)

Read more about Frequent detection but lack of infectivity of SARS-CoV-2 RNA in pre-symptomatic, infected blood donor plasma (Aim 3)

The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): a research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan

Read more about The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): a research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan

Donor Genetic and Non-Genetic Factors Affecting Red Blood Cell Transfusion Effectiveness

Read more about Donor Genetic and Non-Genetic Factors Affecting Red Blood Cell Transfusion Effectiveness

Minipool Testing for SARS-CoV-2 RNA in United States Blood Donors

Read more about Minipool Testing for SARS-CoV-2 RNA in United States Blood Donors

Surveillance of U.S. Blood Donors for SARS-CoV-2 Antibodies: Basis for an expanded National Donor Serosurveillance Program

Read more about Surveillance of U.S. Blood Donors for SARS-CoV-2 Antibodies: Basis for an expanded National Donor Serosurveillance Program

Pagination

  • « First First page
  • ‹ Previous Previous page
  • 1
  • 2
  • 3
  • 4
  • Next › Next page
  • Last » Last page
Subscribe to

This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this U.S. Government sponsored website. Anyone accessing this web site expressly consents to monitoring, recording and subject to audit of their actions and all communication or data transiting or stored on or related to this web site and is advised that if such monitoring reveals possible evidence of criminal activity, NIH may provide that evidence to law enforcement officials.